Safely, tolerability, and mechanisms of antiretroviral activity of pegylated interferon alfa-2a in HIV-1monoinfected participants: A phase II clinical trial

David Asmuth, Robert L. Murphy, Susan L. Rosenkranz, Juan J L Lertora, Shyam Kottilil, Yoninah Cramer, Ellen S. Chan, Robert T. Schooley, Charles R. Rinaldo, Nathan Thielman, Xiao Dong Li, Sharon M. Wahl, Jessica Shore, Jennifer Janik, Richard A. Lempicki, Yaa Simpson, Richard B Pollard

Research output: Contribution to journalArticle

86 Scopus citations

Fingerprint Dive into the research topics of 'Safely, tolerability, and mechanisms of antiretroviral activity of pegylated interferon alfa-2a in HIV-1monoinfected participants: A phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences